Coroner urges TGA review of unapproved peptides after Australian actor Richard Norton's death

A coroner is calling on Australia's Therapeutic Goods Administration (TGA) to review regulations on unapproved peptides following the death of veteran actor and martial artist Richard Norton. Norton, 75, died in March 2025 after injecting prescribed but unapproved CJC1295 and ipamorelin, substances often used for anti-aging and muscle growth. The coroner's recommendation could lead to stricter oversight of these compounds, which are currently accessible through compounding pharmacies but lack TGA approval for safety and efficacy. Norton's death highlights the potential cardiac risks associated with off-label peptide use, especially among older adults. With the global wellness industry booming, regulators face pressure to balance patient access with public safety. The TGA's response will be closely watched by health professionals and consumers alike.